NSW Cancer Research Education State-wide Seminar Series March 2023
Educational Molecular Tumour Board: Precision Oncology for Ovarian CancerSydney Cancer Partners, in collaboration with the Maridulu Budyari Gumal (SPHERE) Cancer CAG and the NSW Regional Cancer Research Network, will be hosting the 2023 NSW Cancer Research Education State-wide Seminar Series. These online seminars will be held on the 3rd Tuesday of each month.
The INOVATe Study (Individualised Ovarian Cancer Treatment Through Integration of Genomic Pathology into Multidisciplinary Care), is a major precision oncology program that has enrolled over 750 women in NSW since 2016. The goal is to facilitate recruitment to Phase I/II clinical trials of targeted cancer treatments through multi-modal molecular testing. In this Molecular Tumour Board session, members of the INOVATe team will provide an overview of the program and present some illustrative cases.
Professor Anna DeFazio, Director Sydney Cancer Partners; Sydney West Chair of Translational Cancer Research, The University of Sydney
Clinical Associate Professor Rosemary Balleine, Clinical and Strategic Partnerships Lead, Sydney Cancer Partners
Dr Cristina Mapagu, Medical Oncologist, ISLHD; Clinical Research Fellow, INOVATe